Rolke James
Revelation Biosciences, Inc. · Chief Executive Officer
Rolke James is listed in filings as Chief Executive Officer at Revelation Biosciences, Inc.. This profile follows SEC Form 4 activity through May 1, 2026, including 5 public disclosures. Recent filings connect the profile to Revelation Biosciences, Inc. (REVBW). The current snapshot covers public activity from Feb 13, 2025 to May 1, 2026. Reported amounts are shown as $11.4K to $479.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||